Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro (tirzepatide) has a half-life of approximately five days, meaning it takes around four to five weeks for a single dose to leave your system almost entirely after your last injection. That timeline shapes several real decisions (from planning surgery to switching medicines to restarting contraception) and understanding it is more useful than a single yes/no answer. As a prescription-only medicine, any decision about stopping, pausing or restarting tirzepatide should be made with your prescriber, not based on a rule of thumb alone.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Every medicine clears the body at a rate set by its half-life: the time it takes for the concentration in your blood to halve. For tirzepatide, that figure is close to five days. Apply the standard pharmacokinetic rule of five half-lives and you arrive at roughly 25 days, or just under four weeks, by which point the drug is below clinically meaningful levels. Allowing a little extra for individual variation in metabolism, most clinicians and the NHS medicines information on tirzepatide support a four-to-five-week working estimate.
That estimate assumes you are at a steady-state dose, one you have been taking consistently for several weeks. If you took only one or two injections at 2.5 mg before stopping, clearance will be faster, because the amount of drug in your body was lower to begin with. The direction runs the other way too: a long run at 10 mg or 15 mg means a larger reservoir to clear, and the upper end of four to five weeks is more realistic.
One important nuance: clearance of the molecule and disappearance of its effects are not the same thing. If you are asking how long till Mounjaro is out of your system, it helps to know that appetite suppression, reduced hunger between meals, and slower gastric emptying can outlast the measurable drug by days or, for some people, a couple of weeks longer. That is actually useful information if you are weighing up what stopping will feel like.
The four-to-five-week figure matters most in four practical situations, and the right answer differs in each. Surgery is the most time-sensitive. Anaesthetists have raised concerns about aspiration risk in patients with slowed gastric emptying; NHS England advises telling your surgical team that you take tirzepatide, and some anaesthetists request a pause of four or more weeks before a general anaesthetic. If an operation is coming up, discuss this early, even a planned procedure scheduled around a payday or a holiday in the diary can run short on lead time if the conversation happens too late.
The second situation is switching medicines. If your prescriber is moving you from tirzepatide to a GLP-1-only medicine such as semaglutide, understanding how long Mounjaro is out of your system helps avoid overlapping pharmacological effects. Third, some women on oral contraceptives need to consider the interaction window: because tirzepatide slows gastric absorption, an additional non-oral contraceptive method is recommended for the first four weeks of treatment and for four weeks after each dose increase. Stopping tirzepatide reverses that effect, but the timing of when the pill reliably re-establishes full absorption is a question for your GP or prescriber, not a fixed rule to apply yourself.
Fourth, if you are planning a pregnancy, current guidance recommends stopping tirzepatide and allowing time for full clearance before trying to conceive. Knowing how long until Mounjaro is out of your system gives you a pharmacokinetic minimum of four to five weeks, but your prescriber may advise a longer pause. Our guide to how long Mounjaro stays in your system covers these scenarios in more detail.
Clinical trial data and real-world experience both show that the physiological changes tirzepatide produces (reduced appetite, lower food intake, weight loss) do not persist indefinitely once the medicine is gone. The underlying biology that made weight loss difficult in the first place reasserts itself for most people, typically within weeks to a few months of stopping. This is not a failure of willpower; it reflects how the body regulates hunger and energy balance. The NICE technology appraisal for tirzepatide (TA1026) notes that continuing treatment is reviewed if sufficient weight loss is not maintained, precisely because stopping is not a neutral event.
For people who stop intentionally (because of surgery, pregnancy planning, a temporary supply gap, or a clinical decision) the practical message is that reintroduction will likely require starting at a lower dose again to minimise side effects. That titration decision belongs with your prescriber. If you are thinking about what stopping might mean for your results over time, our page on how tirzepatide affects fat loss addresses the underlying mechanism.
It is also worth noting what stopping does not necessarily mean: short gaps of a week or two, through a missed injection rather than a deliberate stop, produce a gentler effect. The medicine's long half-life provides a degree of buffer. But that buffer shrinks quickly beyond two missed doses, which is another reason not to treat tirzepatide as something you can casually pause and restart without clinical input.
If you are trying to time a pause around surgery, a pregnancy plan, a medicine switch, or simply because your circumstances have changed, the most reliable step is to speak with a prescriber who knows your history on treatment. At nume, a GPhC-registered Independent Prescriber personally reviews every consultation, the same day it is submitted. There is no algorithm making those calls.
For a broader look at how tirzepatide works and what the clinical evidence says about results, the Mounjaro treatment guide on our site covers the full picture. If you are weighing up whether treatment is right for you at all, our weight-loss treatment overview sets out the options. And if you have questions about the cost of a private prescription, the treatment and consultation page is the clearest place to see what is included.
When you are ready to speak to our prescribers, start your free consultation, there is no obligation, and it is the fastest way to get advice that actually fits your situation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.